In contrast, another study using prospective samples from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial in the United States observed no associations between multiple myeloma risk and FGF-2, VEGF, and TGF-α levels (12). This evidence concerns the gene VEGFA and AL amyloidosis.